Indegene, FindMeCure and European Patients’ Academy on Therapeutic Innovation (EUPATI) have joined hands to drive advancement and innovation in treatment practices through greater patient engagement in clinical research. By working with FindMeCure’s feasibility data intelligence platform, Indegene aims to further the cause of delivering affordable patient-centric care.
In line with this, Indegene’s donation to the EUPATI patient education scholarship is another step toward enhancing the overall effectiveness of the clinical development process. The company’s contribution aims to boost patient inclusion efforts, aid successful clinical trials, and help bring innovative treatments to the market with EUPATI’s Patient Expert programme.
EUPATI is a multi-stakeholder public-private partnership launched in 2012. It provides accessible and innovative education aimed at empowering patients and patient representatives. With patient inclusivity and stakeholder partnership at its core, it enriches the medicines’ R&D process. EUPATI’s commitment to enhancing patient engagement through education is a mission that many leading industry organisations like FindMeCure support.